Deepbridge Capital — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
Microplate Dx is a diagnostics company developing rapid antimicrobial susceptibility testing technology to identify the correct antibiotic treatment for infections within hours, enabling faster patient treatment and reducing antibiotic resistance.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesGlasgow, GB
Dr Stuart Hannah(Co-Founder & CEO)in
BoardPoonam Malik(Director)Andrew Justin Radcliffe Porter(Director)
Co-investorsScottish Enterprise
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
GenoMe DiagnosticsIbisVision
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.